VRAX – virax biolabs group limited - ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

VRAX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/15

07:47 am

vrax

Virax Biolabs Group (NASDAQ:VRAX) was upgraded by analysts at Zacks Research to a "hold" rating.

Medium Report

Virax Biolabs Group (NASDAQ:VRAX) was upgraded by analysts at Zacks Research to a "hold" rating.

Report

1/13

04:06 am

vrax

Virax Biolabs Group (NASDAQ:VRAX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Medium Report

Virax Biolabs Group (NASDAQ:VRAX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Report

1/9

12:46 pm

vrax

Virax Biolabs Group (NASDAQ:VRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock, down previously from $3.00.

Medium Report

Virax Biolabs Group (NASDAQ:VRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $1.00 price target on the stock, down previously from $3.00.

Report

12/4

04:50 pm

vrax

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement [Yahoo! Finance]

Low Report

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement [Yahoo! Finance]

Report

12/4

04:05 pm

vrax

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Low Report

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.